Insight Molecular Diagnostics I (IMDX) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 65.7%
EBITDA Margin: -4492.5%
Op. Margin: -4770.7%
Net Margin: -4711.3%

Op. margin of -4770.7% is down 2870.7% YoY — costs are rising relative to revenue. Net margin at -4711.3% and gross margin of 65.7% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit